Curis
CRIS
#10294
Rank
NZ$19.27 M
Marketcap
NZ$1.49
Share price
-1.39%
Change (1 day)
-76.41%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): NZ-$6.38

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$6.09. In 2024 the company made an earnings per share (EPS) of NZ-$11.67 an increase over its 2023 EPS that were of NZ-$14.99.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.38-45.32%
2024NZ-$11.67-22.15%
2023NZ-$14.99-26.17%
2022NZ-$20.3122.3%
2021NZ-$16.60-25.37%
2020NZ-$22.25-30.93%
2019NZ-$32.21-2.02%
2018NZ-$32.88
2016NZ-$74.72-10%
2015NZ-$83.02138.1%
2014NZ-$34.8740%
2013NZ-$24.91-25%
2012NZ-$33.2166.67%
2011NZ-$19.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.86-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$4.93-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.60-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$3.95-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$5.61-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$18.66 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.34-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA